gvtcx

Investment Management Services

Cancer Research Wales Published 28 Sept 2023 Sell2Wales

key details

Category (CPV) 66100000 +3 more
Deadline4 Sept 2023
Procedureopen
OCIDocds-kuma6s-134078

Award

SupplierValueDateStatus
Brewin Dolphin Limited · · ·

description

  1. CRW has an investment portfolio as at 31 March 2023 of £4.5 million invested within the ethical markets.3.2 As a Cancer Research Charity, investments in any tobacco related products is prohibited and this is a non negotiable condition.3.3 The investment portfolio is held to provide a financial return in the form of interest receivable and investment gains to fund our Research Strategy3.4 The appointed supplier will be responsible for, but shall not be limited to:I. Reviewing the current Investment Policy and making recommendations as appropriate..II. Make investment decisions in line with the Investment Policy.III. Provide Quarterly reviews and an annual review of the Investment PortfolioIV. Provide relevant information to enable the preparation of the Charities Financial StatementsV. Act as a sounding board and advisor.VI. Actively engage in the activities of the Charity to understand the work we do, challenges and opportunities.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

more from Cancer Research Wales

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Sell2Wales. Contact details for named individuals are not reproduced on this site.